B71.1: Cutaneous leishmaniasis
ICD-10 B71.1 is a billable code used to indicate a diagnosis of b71.1: cutaneous leishmaniasis.
Cutaneous leishmaniasis is a parasitic infection caused by protozoa of the genus Leishmania, primarily transmitted through the bite of infected sandflies. This condition is characterized by the development of skin lesions, which can vary from small papules to larger ulcers, often leading to significant morbidity. The lesions typically appear weeks to months after the initial bite and can be painful and disfiguring. Cutaneous leishmaniasis is endemic in many tropical and subtropical regions, including parts of the Middle East, Africa, and South America. Diagnosis is primarily clinical, supported by laboratory tests such as skin biopsy or serological assays. Treatment options include topical therapies, systemic antimonials, and newer agents like miltefosine, depending on the severity and extent of the disease. Understanding the epidemiology, clinical presentation, and treatment options is crucial for effective management and coding of this condition.
Detailed travel history, exposure risk, and clinical findings.
Patients presenting with skin lesions after travel to endemic areas.
Ensure accurate documentation of lesion characteristics and treatment response.
Photographic evidence of lesions, biopsy results, and treatment plans.
Patients with chronic skin ulcers or lesions suspected to be leishmaniasis.
Document differential diagnoses to avoid misclassification.
Used when a biopsy is performed to confirm diagnosis.
Include pathology report and clinical notes.
Ensure the biopsy site is documented clearly.
Cutaneous leishmaniasis is primarily caused by protozoan parasites of the genus Leishmania, transmitted through the bite of infected sandflies.
Diagnosis is typically made through clinical evaluation, supported by laboratory tests such as skin biopsy or serological assays.
Treatment options include topical therapies, systemic antimonials, and newer agents like miltefosine, depending on the severity of the disease.
